Malignancy and hyperplasia Library
Learn more about the prevalence, symptoms, diagnosis and treatment of abnormal uterine bleeding caused by malignancy and hyperplasia (termed AUB-M in the PALM-COEIN classification).
PUBLICATIONS
FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions
Munro MG, et. al. for the FIGO Menstrual Disorders Committee. Int J Gynaecol Obstet. 2019 Feb;144(2):237]. Int J Gynaecol Obstet. 2018;143(3):393-408.
The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis
Dijkhuizen FP, et al. Cancer 2000;89:1765–72
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia
Lacey JV Jr, et. al. J Clin Oncol. 2010;28(5):788-792.
LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study
Gallos ID, et. Al. Hum Reprod. 2013;28(11):2966-2971
Endorsed by
